Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7347 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Launch of new podcast series Trusting the Science

The Oxford Vaccine Group is celebrating 30 years of life-saving vaccine development with the release of a new podcast series of conversations called Trusting the Science. This is the second series of The Oxford Colloquy - a series of discourses hosted by Professor Sir Andrew Pollard who has been Director of the group for over 20 years - and each episode delves into the crucial role that science plays in our understanding of health and immunity.

EDI Steering Group Seeks Members

Sixty Seconds with Pete Jones, Head of Technology

Tim Denison elected a Fellow of the Royal Academy of Engineering

Many congratulations to BNDU Group Leader Professor Tim Denison on the announcement today of his election to the Fellowship of the Royal Academy of Engineering.

Researchers develop new tool to better predict AML outcomes in older patients

In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.

Antibiotic resistance has claimed at least one million lives each year since 1990: GRAM

Landmark GRAM Project study of global AMR burden over time forecasts a sharp rise in deaths, with 39 million lives lost between now and 2050

New trial to test potential treatment for chronic kidney disease

A new multinational clinical trial will investigate whether a novel treatment can help slow the progression of chronic kidney disease (CKD). The first participants have been recruited.

Study discovers new process for cells to repair DNA damage

A team of international researchers at the University of Oxford (Oxford) and Nanyang Technological University, Singapore (NTU Singapore), has discovered a new process for repairing damaged DNA that is particularly relevant for patients undergoing colorectal cancer treatments.

Study increases understanding of lung microbiome in severe asthma patients

Respiratory researchers in Oxford have discovered a link between potentially pathogenic bacteria and airways inflammation in severe asthma.

Impact of social factors on suicide must be recognised

The impact of social factors such as poverty and abuse on suicide need to be recognised and action taken to address them, according to a major series of papers published in the Lancet Public Health on World Suicide Prevention Day.

Piloting new Enterprise Service Management system

Department of Paediatrics awarded a Gold Athena Swan award

New MSD Mediation Service seeks interested staff to become accredited Mediators

Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome

Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.

Robust memory of a previous event shown to prevent new flexible memories from being formed

Researchers at the Medical Research Council Brain (MRC) Network Dynamics Unit in Oxford's Nuffield Department of Clinical Neurosciences have discovered a new neuronal mechanism in the hippocampus, that prevents new ‘flexible’ memories from being formed due to a past ‘robust’ memory.

Professor Sarah Harper announced as new chair of HelpAge International Board of Trustees

HelpAge International has appointed Sarah Harper, Clore Professor of Gerontology at the University of Oxford and founder of Oxford’s Institute of Population Ageing, as the new Chair of the Board of Trustees.

Professor Ole Jensen appointed to Professorship of Translational Cognitive Neuroscience

Professor Ole Jensen has been appointed Chair of Translational Cognitive Neuroscience at the University of Oxford, working across both the Department of Psychiatry and Experimental Psychology.

September 2024 - Volunteer opportunities

Six Oxford researchers awarded European Research Council Starting Grants to launch ambitious projects

Today, the European Research Council (ERC) - the premier European funding organisation for excellent frontier research - has announced the awarding of 494 major European Research Council (ERC) Starting Grants to young scientists and scholars across Europe, including six Oxford University researchers. The funding - totalling nearly €780 million this year– is part of the Horizon Europe programme and will support researchers at the beginning of their careers to launch their own projects, form their teams, and pursue their most promising ideas.

New method developed to detect fake vaccines in supply chains

Research published this week and led by University of Oxford researchers describes a first-of-its-kind method capable of distinguishing authentic and falsified vaccines by applying machine learning to mass spectral data. The method proved effective in differentiating between a range of authentic and ‘faked’ vaccines previously found to have entered supply chains.

Load More